|
| Status |
Public on May 22, 2015 |
| Title |
RNA-seq in two ER+ breast cancer cell lines with and without progestins |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
Exploring effect of progesterone/progestin treatment on gene expression
|
| |
|
| Overall design |
Two cell lines, three conditions (Full Media with E2, E2+ Progesterone, Full Media + R5020 Progestin)
|
| |
|
| Contributor(s) |
Mohammed H, Stark R, Menon S |
| Citation(s) |
26153859 |
| |
| Submission date |
Apr 28, 2015 |
| Last update date |
May 15, 2019 |
| Contact name |
Chandra Chilamakuri |
| E-mail(s) |
datasubmissions@cruk.cam.ac.uk
|
| Organization name |
Cancer Research UK Cambridge Institute
|
| Street address |
Robinson Way
|
| City |
Cambridge |
| ZIP/Postal code |
CB2 0RE |
| Country |
United Kingdom |
| |
|
| Platforms (1) |
| GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
|
| Samples (48)
|
|
| This SubSeries is part of SuperSeries: |
| GSE68359 |
Progesterone receptor directs a distinct estrogen receptor-alpha chromatin binding profile in breast cancer to elicit good clinical outcome |
|
| Relations |
| BioProject |
PRJNA282505 |
| SRA |
SRP057758 |
Less...
More...